Authors: Tzavara, ET Monory, K Garel, S Topilko, P Charnay, P Hanoune, J

Citation: Et. Tzavara et al., Effects of cannabinoids in Krox-24 targeted mice, NEUROREPORT, 12(7), 2001, pp. 1367-1370

Authors: Tzavara, ET Perry, KW Rodriguez, DE Bymaster, FP Nomikos, GG

Citation: Et. Tzavara et al., The cannabinoid CB1 receptor antagonist SR141716A increases norepinephrineoutflow in the rat anterior hypothalamus, EUR J PHARM, 426(3), 2001, pp. R3-R4

Authors: Mas-Nieto, M Pommier, B Tzavara, ET Caneparo, A Da Nascimento, S Le Fur, G Rogues, BP Noble, F

Citation: M. Mas-nieto et al., Reduction of opioid dependence by the CB1 antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction, BR J PHARM, 132(8), 2001, pp. 1809-1816

Authors: Tzavara, ET Valjent, E Firmo, C Mas, M Beslot, F Defer, N Roques, BP Hanoune, J Maldonado, R

Citation: Et. Tzavara et al., Cannabinoid withdrawal is dependent upon PKA activation in the cerebellum, EUR J NEURO, 12(3), 2000, pp. 1038-1046

Authors: Hutcheson, DM Tzavara, ET Smadja, C Valjent, E Roques, BP Hanoune, J Maldonado, R

Citation: Dm. Hutcheson et al., Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with Delta-9-tetrahydrocannabinol, BR J PHARM, 125(7), 1998, pp. 1567-1577